|
![]() |
|||
|
||||
OverviewAcute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children, representing nearly one third of all pediatric cancers. The annual incidence of ALL is about 30 cases per million people, with a peak incidence in children aged 2-5 years. Although a few cases are associated with inherited genetic syndromes, the cause of ALL remains largely unknown. This issue presents articles that discuss current thinking on the diagnosis and treatment of the disease. Articles specifically emphasize molecular genetics, allogeneic stem cell transplantation, and treatments including, clofarabine, nelarabine, rituximab, and PegAsp. Full Product DetailsAuthor: Wendy Stock , Meir WetzlerPublisher: Elsevier Health Sciences Imprint: W B Saunders Co Ltd Volume: 23-5 Dimensions: Width: 15.20cm , Height: 1.50cm , Length: 22.90cm Weight: 0.460kg ISBN: 9781437712278ISBN 10: 1437712274 Publication Date: 17 November 2009 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |